Entertainment
View All
Longwood Gardens’ Garden Glow Lights Up Kennett Square Nights
KENNETT SQUARE, PA — When the sun goes down this winter, Longwood Gardens is turning up the light.
Lifestyle
View All
The Sound of Home: Why the Philadelphia Accent Is Quietly Fading
The bartender leans across the polished wood in South Philly and asks if you want “wooder.” He doesn’t blink when he says it. The word lands soft and rounded, more …
Pennsylvania
View All
Variable Speed Limits Reduce Winter Crashes on Key Pennsylvania Highways
What This Means for You Electronic variable speed limits automatically lower speeds on parts of Interstates 80 and 81 during dangerous winter conditions. Reduced limits are enforceable, and citations may …
National
View All
McCormick Warns of ‘Election Vulnerabilities,’ Backs SAVE America Act
WASHINGTON, D.C. — U.S. Sen. Dave McCormick, R-Pa., took to the Senate floor Thursday to forcefully defend the SAVE America Act, arguing the legislation is necessary to “restore America’s trust” …
Latest Articles
View All
Essential Utilities Sets Date for 2025 Earnings Reveal
BRYN MAWR, PA — Essential Utilities, Inc. (NYSE: WTRG) will report its full-year 2025 financial results after the market closes on Wednesday, February 25, 2026, setting the stage for what …
PSP Avondale Reports Crash, Domestic Incidents and Identity Thefts Across Southern Chester County
AVONDALE, PA — Pennsylvania State Police at Avondale reported multiple incidents across southern Chester County between January 10 and February 12, including a crash with injuries, domestic-related investigations and identity …
Longwood Gardens’ Garden Glow Lights Up Kennett Square Nights
KENNETT SQUARE, PA — When the sun goes down this winter, Longwood Gardens is turning up the light.
Malvern-Based PQ Named 2025 Supplier of the Year by Nouryon
MALVERN, PA — PQ has been named a 2025 Supplier of the Year by Nouryon, a distinction the company said reflects a deep operational partnership and coordinated efforts across global …
Experimental Pompe Therapy Shows Early Promise in Trial
PHILADELPHIA, PA — Aro Biotherapeutics reported interim data from a Phase 1b study of ABX1100, an investigational therapy for late-onset Pompe disease, showing the drug was generally well tolerated and …